Connect with Form Bio at these upcoming events.
Our Chief Strategy Officer, Claire Aldridge, PhD, explores the growing trend of early integration of biomanufacturing design to cut costs and time-to-market while improving patient access to gene therapy.
Single-cell analysis techniques and multi-omics are providing a newfound understanding of hidden complexity in biological systems, revolutionizing the biomanufacturing process for cell and gene therapies. Here’s how.
We support the commitment of the Biden-Harris Administration to address global issues through biomanufacturing innovation. Learn more.
